Screener
MiMedx Group MDXG Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 78.8%-2.6pp | 81%-0.9pp | 82.6%-0.2pp | 82%-1.4pp | 81.5%-2.0pp | |
| Operating margin | 2.5%-9.3pp | 10.2%-5.1pp | 15.3%-1.6pp | 13.7%-8.1pp | 11.8%-10.1pp | |
| Net margin | 1.8%-7.1pp | 7.9%-3.5pp | 11.6%-0.6pp | 10.4%-15.4pp | 8.8%-17.3pp | |
| Returns | ||||||
| Return on equity | 2.9%-13.8pp | 13.8%-8.6pp | 21.6%-3.7pp | 19.4%-77.6pp | 16.7%— | |
| Return on invested capital | 4.4%-21.9pp | 26.6%-6.1pp | 41.4%+3.1pp | 34.9%— | 26.4%— | |
| Efficiency | ||||||
| Asset turnover | 1.2×-0.2× | 1.3×-0.1× | 1.4×0.0× | 1.4×-0.2× | 1.4×-0.3× | |
| Liquidity | ||||||
| Current ratio | 5.3×+0.9× | 5.4×+0.7× | 4.3×+0.1× | 4.4×+0.3× | 4.4×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -7.1×-5.2× | -2.8×-1.4× | -1.8×-0.6× | -1.9×-1.0× | -1.9×-1.3× | |
| Per Share | ||||||
| Book value per share | $1.46+0.7% | $1.64+20.8% | $1.71+32.3% | $1.60+30.8% | $1.45+28.5% | |
| Valuation | ||||||
| Market capitalization | $632.6M-39.3% | $586.84M-47.6% | $1B-29.1% | $1.03B+19.0% | $880.3M-13.9% | |
| Price / earnings | 101.4×+69.0× | 19.1×-8.8× | 20.6×-12.7× | 25.3×+15.5× | 27.4×+15.9× | |
| Price / sales | 1.8×-1.1× | 1.5×-1.7× | 2.4×-1.7× | 2.6×+0.1× | 2.4×-0.6× | |
| Price / book | 2.9×-1.9× | 2.4×-3.1× | 3.9×-3.4× | 4.3×-0.5× | 4.1×-2.0× | |
| EV / EBITDA | 30.6×+13.0× | 8.7×-7.9× | 10.9×-9.6× | 13.7×+3.7× | 14.6×+2.3× |
FAQ
- What are MiMedx Group's profit margins?
- MiMedx Group (MDXG) runs a 78.8% gross margin and a 2.5% operating margin, with a 1.8% net margin.
- Where do MiMedx Group's ratios come from?
- Every ratio is computed from MiMedx Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
